AbbVie's market cap is currently $413.22B. The company's EPS TTM is $2.97; its P/E ratio is 111.32; and it has a dividend yield of 2.81%. AbbVie is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $3.27. See an overview of income statement, balance sheet, and cash flow financials.
